463 million. That’s the number of people around the world currently living with diabetes, according to the International Diabetes Federation (IDF). And it’s estimated that the figure will jump further to 578 million by 2030,…
Read more
Machine learning powers many of the services we regularly use, from personalized recommendations on Netflix and Spotify to voice assistants such as Siri or Alexa. In recent years, machine learning has gained momentum in healthcare…
Read more
Healthcare is transitioning to a patient-centric approach powered by healthcare consumerism. Patients have fast become consumers first, and with the freedom to make decisions about their health journeys, they’re looking for healthcare choices that put…
Read more
By the year 2030 the entire Baby Boomer generation will be age 65 or older. This growing number of senior Boomers will challenge the health care system, particularly when it comes to medication management and…
Read more
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels including emails and SMS text messages. In a trial of…
Read more
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of…
Read more
Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer medications (OAMs). There…
Read more
AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient…
Read more
Medication non-adherence continues to be one of the most widespread issues faced by the pharmaceutical industry. According to the U.S. Centers for Disease Control, approximately 50 percent of people with chronic illnesses stop taking their…
Read more
Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play…
Read more
We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise…
Read more
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of…
Read more
What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards…
Read more
AllazoHealth, a company that uses artificial intelligence (AI) to help enterprise healthcare companies improve medication adherence and quality outcomes, has released a new study demonstrating the impact of AI on patient adherence indicators. The poster…
Read more